BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 9042024)

  • 1. Leukotrienes in the pathogenesis of asthma.
    O'Byrne PM
    Chest; 1997 Feb; 111(2 Suppl):27S-34S. PubMed ID: 9042024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamic properties of leukotriene receptor antagonists.
    Nicosia S
    Monaldi Arch Chest Dis; 1999 Jun; 54(3):242-6. PubMed ID: 10441979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physiopathology of asthma: what role for leukotrienes?].
    Lockhart A; Dinh-Xuan AT
    Rev Pneumol Clin; 1997; 53(3):119-27. PubMed ID: 9296112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part I: synthesis, receptors and role of leukotrienes in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):3-13. PubMed ID: 10378985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of leukotrienes in asthma.
    Henderson WR
    Ann Allergy; 1994 Mar; 72(3):272-8. PubMed ID: 8129221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonic acid metabolites: mediators of inflammation in asthma.
    Wenzel SE
    Pharmacotherapy; 1997; 17(1 Pt 2):3S-12S. PubMed ID: 9017783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of peptide-leukotrienes in bronchial asthma].
    Kohno S
    Nihon Yakurigaku Zasshi; 1998 Apr; 111(4):223-31. PubMed ID: 9618707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
    Drazen JM
    Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
    Bisgaard H
    Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives for asthma treatment: anti-leukotriene drugs.
    GarcĂ­a-Marcos L; Schuster A
    Pediatr Allergy Immunol; 1999 May; 10(2):77-88. PubMed ID: 10478608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Zafirlukast (Accolate): a review of its pharmacological and clinical profile].
    Murata Y; Sugimoto O
    Nihon Yakurigaku Zasshi; 2002 Apr; 119(4):247-58. PubMed ID: 11979731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of leukotrienes and development of antileukotriene agents.
    Leff AR;
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6 Suppl 1):4-8. PubMed ID: 11426915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma.
    Kay AB
    Eur J Respir Dis Suppl; 1983; 129():1-44. PubMed ID: 6418559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma.
    Bjermer L; Diamant Z
    Monaldi Arch Chest Dis; 2002 Feb; 57(1):76-83. PubMed ID: 12174707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukotriene D
    Al-Azzam N; Elsalem L
    Life Sci; 2020 Nov; 260():118452. PubMed ID: 32956660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro.
    Liu YC; Khawaja AM; Rogers DF
    Br J Pharmacol; 1998 Jun; 124(3):563-71. PubMed ID: 9647482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
    Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
    Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthmatic airways have a disproportionate hyperresponsiveness to LTE4, as compared with normal airways, but not to LTC4, LTD4, methacholine, and histamine.
    Arm JP; O'Hickey SP; Hawksworth RJ; Fong CY; Crea AE; Spur BW; Lee TH
    Am Rev Respir Dis; 1990 Nov; 142(5):1112-8. PubMed ID: 2173457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leukotriene modifiers].
    Minoguchi K; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1979-85. PubMed ID: 11676142
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.